JP2015509966A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509966A5
JP2015509966A5 JP2014561430A JP2014561430A JP2015509966A5 JP 2015509966 A5 JP2015509966 A5 JP 2015509966A5 JP 2014561430 A JP2014561430 A JP 2014561430A JP 2014561430 A JP2014561430 A JP 2014561430A JP 2015509966 A5 JP2015509966 A5 JP 2015509966A5
Authority
JP
Japan
Prior art keywords
formula
compound according
represented
group
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014561430A
Other languages
English (en)
Japanese (ja)
Other versions
JP6375231B2 (ja
JP2015509966A (ja
Filing date
Publication date
Priority claimed from EP12159378.4A external-priority patent/EP2639227A1/en
Application filed filed Critical
Publication of JP2015509966A publication Critical patent/JP2015509966A/ja
Publication of JP2015509966A5 publication Critical patent/JP2015509966A5/ja
Application granted granted Critical
Publication of JP6375231B2 publication Critical patent/JP6375231B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014561430A 2012-03-14 2013-03-13 新しいクラスのジアゼピン誘導体キレート化剤およびmri造影剤としてのその常磁性金属との錯体 Active JP6375231B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12159378.4A EP2639227A1 (en) 2012-03-14 2012-03-14 A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents
EP12159378.4 2012-03-14
PCT/EP2013/055094 WO2013135750A1 (en) 2012-03-14 2013-03-13 A new class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as mri contrast agents

Publications (3)

Publication Number Publication Date
JP2015509966A JP2015509966A (ja) 2015-04-02
JP2015509966A5 true JP2015509966A5 (enExample) 2016-04-28
JP6375231B2 JP6375231B2 (ja) 2018-08-15

Family

ID=47846054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014561430A Active JP6375231B2 (ja) 2012-03-14 2013-03-13 新しいクラスのジアゼピン誘導体キレート化剤およびmri造影剤としてのその常磁性金属との錯体

Country Status (7)

Country Link
US (1) US9259491B2 (enExample)
EP (2) EP2639227A1 (enExample)
JP (1) JP6375231B2 (enExample)
CN (1) CN104203926B (enExample)
AU (1) AU2013231301B2 (enExample)
CA (1) CA2863784C (enExample)
WO (1) WO2013135750A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2892570B1 (en) * 2012-09-07 2019-02-27 Bracco Imaging S.p.A Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri
US10251960B2 (en) 2013-05-30 2019-04-09 Bracco Imaging S.P.A. Fluorescent solid lipid nanoparticles composition and preparation thereof
US11370826B2 (en) 2016-02-09 2022-06-28 Bracco Suisse Sa Recombinant chimeric protein for selectins targeting
WO2017147418A1 (en) 2016-02-24 2017-08-31 Ohio State Innovation Foundation Methods and devices for contrast agent magnetic resonance imaging
DE102017129405A1 (de) 2017-12-11 2019-06-13 Universitätsklinikum Jena Neue DAZA-Chelatoren als Liganden in der Leberbildgebung
US11684682B2 (en) 2018-11-12 2023-06-27 Bracco Imaging S.P.A. Chelating AAZTA conjugates and complexes thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
US5833948A (en) 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
EP1105162A1 (en) * 1998-08-10 2001-06-13 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
FR2795412B1 (fr) * 1999-06-23 2001-07-13 Adir Nouveaux derives d'ammonium quaternaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITMI20011518A1 (it) 2001-07-17 2003-01-17 Bracco Imaging Spa Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia
US7893223B2 (en) * 2001-07-17 2011-02-22 Bracco Imaging S.P.A. Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
US7922998B2 (en) 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
GB0305422D0 (en) * 2003-03-10 2003-04-16 Univ Open Detection, monitoring and treatment of cancer
US7988950B2 (en) * 2004-07-02 2011-08-02 Bracco Imaging S.P.A. Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
EP1964846A1 (en) * 2007-02-27 2008-09-03 Bracco Imaging, S.P.A. Process for the preparation of contrast agents
FR2939318B1 (fr) * 2008-12-10 2012-07-13 Guerbet Sa Systeme d'encapsulation pour imagerie cest avec quelate q superieur ou egal a 2

Similar Documents

Publication Publication Date Title
JP2015509966A5 (enExample)
CY1124882T1 (el) Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn
JP2013032389A5 (enExample)
JP2014506907A5 (enExample)
JP2018518537A5 (enExample)
JP2016527277A5 (enExample)
JP2010500343A5 (enExample)
JP2017537940A5 (enExample)
JP2017511321A5 (enExample)
JP2011518833A5 (enExample)
JP2013505946A5 (enExample)
JP2012513416A5 (enExample)
JP2016516767A5 (enExample)
JP2014510774A5 (enExample)
JP2019516739A5 (enExample)
SG10201806565SA (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
JP2015535847A5 (enExample)
PH12016500249B1 (en) Diazacarbazole derivatives as tau-pet-ligands
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
MX2014006366A (es) Metodos y composiciones para reducir la grasa y los adipocitos del cuerpo.
JP2015512943A5 (enExample)
JP2016529319A5 (enExample)
IN2015DN00837A (enExample)
MX2018001145A (es) Métodos para la preparación de ácidos biliares y derivados de los mismos.
MX377202B (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.